A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza

Inclusion Criteria

• •Adult and adolescent patients, 13 years of age and older
• •Diagnosis of influenza
• •≤ 144 hours between the onset of influenza-like illness and first dose of study drug
• •Non-randomized, open-label treatment group:
• •Patients with moderate/severe renal impairment or renal failure with creatinine clearance 10-60 mL/min